| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |